Michael J. Scott

OM Group, Inc. is a technology-based industrial growth company. It engages in developing, producing and marketing chemicals, advanced materials and electrochemical energy storage products worldwide. The company operates through the following segments: Magnetic Technologies, Advanced Materials, Specialty Chemicals and Battery Technologies. The Magnetic Technologies segment is engaged in the development, manufacturing and distribution of industrial-use magnetic products and systems for electronic equipment markets, including the renewable energy, automotive systems, construction & mining and industrial sectors. The Advanced Materials segment manufactured inorganic products using unrefined cobalt and other metals and served the mobile energy storage, renewable energy, automotive systems, construction and mining and industrial end markets. The Specialty Chemicals segment develops, produces and supplies chemicals for electronic applications, industrial applications including coatings, composites and tire; and photomasks used by customers to produce semiconductors and related products. The Battery Technologies segment provides advanced batteries, battery management systems, battery-related research and energetic devices for defense, space and medical markets. The company was founded in 1991 and is headquartered in Cleveland, OH.

National Steel Corp. produces, manufactures and sells integrated steel and flat rolled carbon steel products, including hot-rolled, cold-rolled, galvanized, tin and chrome plated steels. The company primarily sells its products to the automotive and construction industry. The company was founded in 1941 and is headquartered in Mishawaka, IN.

Weirton Steel Corp. manufactures tin mill and sheet steel products. The company's tin mill products, includes tin plate, chrome coated and black plate steels and are consumed principally by the container and packaging industry for food cans, general line cans and closure applications, such as caps and lids. The company produces carbon steel slabs in its primary steel making operations from raw materials to industry and customer specifications

ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.

Orqis Medical Corp. develops medical devices and solutions for heart problems. It develops and sells minimally invasive devices that improve cardiac performance through aortic flow therapy. Its products include the CANCION and EXELERAS systems. The company was founded in 1997 and is headquartered in Lake Forest, CA.

Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada.